Discovery and Preliminary Structure–Activity Relationship of Arylpiperazines as Novel, Brain-Penetrant Antiprion Compounds

Por Li, Zhe, Gever, Joel R., Rao, Satish, Widjaja, Kartika, Prusiner, Stanley B., Silber, B. Michael
Publicado em 2013

Towards Optimization of Arylamides As Novel, Potent, and Brain-Penetrant Antiprion Lead Compounds

Por Li, Zhe, Rao, Satish, Gever, Joel R., Widjaja, Kartika, Prusiner, Stanley B., Michael Silber, B.
Publicado em 2013

Purinoceptors as therapeutic targets for lower urinary tract dysfunction

Por Ford, Anthony P D W, Gever, Joel R, Nunn, Philip A, Zhong, Yu, Cefalu, Joseph S, Dillon, Michael P, Cockayne, Debra A
Publicado em 2006

Pharmacological pleiotropism of the human recombinant α(1A)-adrenoceptor: implications for α(1)-adrenoceptor classification

Por Ford, Anthony P D W, Daniels, Donald V, Chang, David J, Gever, Joel R, Jasper, Jeffrey R, Lesnick, John D, Clarke, David E
Publicado em 1997

Antagonism of ATP responses at P2X receptor subtypes by the pH indicator dye, Phenol red

Por King, Brian F, Liu, Min, Townsend-Nicholson, Andrea, Pfister, Jürg, Padilla, Fernando, Ford, Anthony P, Gever, Joel R, Oglesby, Ian B, Schorge, Stephanie, Burnstock, Geoffrey
Publicado em 2005

A High-throughput Screening Assay for Determining Cellular Levels of Total Tau Protein

Por Dehdashti, Seameen J., Zheng, Wei, Gever, Joel R., Wilhelm, Robert, Nguyen, Dac-Trung, Sittampalam, Gurusingham, McKew, John C., Austin, Christopher P., Prusiner, Stanley B.
Publicado em 2013

Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells

Por Silber, B. Michael, Gever, Joel R., Li, Zhe, Gallardo-Godoy, Alejandra, Renslo, Adam R., Widjaja, Kartika, Irwin, John J., Rao, Satish, Jacobson, Matthew P., Ghaemmaghami, Sina, Prusiner, Stanley B.
Publicado em 2013

AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist

Por Gever, Joel R, Soto, Rothschild, Henningsen, Robert A, Martin, Renee S, Hackos, David H, Panicker, Sandip, Rubas, Werner, Oglesby, Ian B, Dillon, Michael P, Milla, Marcos E, Burnstock, Geoffrey, Ford, Anthony PDW
Publicado em 2010

Novel compounds lowering the cellular isoform of the human prion protein in cultured human cells

Por Silber, B. Michael, Gever, Joel R., Rao, Satish, Li, Zhe, Renslo, Adam R., Widjaja, Kartika, Wong, Casper, Giles, Kurt, Freyman, Yevgeniy, Elepano, Manuel, Irwin, John J., Jacobson, Matthew P., Prusiner, Stanley B.
Publicado em 2014

Biaryl Amides and Hydrazones as Therapeutics for Prion Disease in Transgenic Mice

Por Lu, Duo, Giles, Kurt, Li, Zhe, Rao, Satish, Dolghih, Elena, Gever, Joel R., Geva, Michal, Elepano, Manuel L., Oehler, Abby, Bryant, Clifford, Renslo, Adam R., Jacobson, Matthew P., DeArmond, Stephen J., Silber, B. Michael, Prusiner, Stanley B.
Publicado em 2013

Pharmacokinetics and Metabolism of 2-Aminothiazoles with Antiprion Activity in Mice

Por Silber, B. Michael, Rao, Satish, Fife, Kimberly L., Gallardo-Godoy, Alejandra, Renslo, Adam R., Dalvie, Deepak K., Giles, Kurt, Freyman, Yevgeniy, Elepano, Manuel, Gever, Joel R., Li, Zhe, Jacobson, Matthew P., Huang, Yong, Benet, Leslie Z., Prusiner, Stanley B.
Publicado em 2013